Aptar Pharma Premiumcoatв Accelerating Derisking Injectable D Presented by a leading expert in injectable drug delivery, this webinar promises to be an invaluable resource for those looking to stay ahead in the development of safe, effective pharmaceutical products. to secure your spot and learn more about how to safeguard your sensitive injectable formulations, register now: register for 9am london session. Discover premiumcoat, aptar pharma’s etfe film coated platform of vial stoppers, syringe components and services that protects your drug and your patients. p.
Aptar Pharma Premiumcoat Accelerating Derisking Injectable Dr Aptar pharma is a global leader in the design and manufacturing of a broad range of pharmaceutical delivery, consumer product dispensing and active material science solutions. our portfolio of vial stoppers, pre filled syringe components and services support our customer’s drug development process to ensure their successful launch and life. The webinar concludes with a review of a case study on the premiumcoat ® plunger, aptar pharma’s best in class platform of closure solutions. the plunger features an ethylene tetrafluoroethylene (etfe) film coating that is applied at the drug contact surface to act as a barrier against e&l. using the simulation study strategy, aptar pharma. Choosing the right packaging for sensitive drugs, new biotech drugs or biosimilar can be a complex and risky exercise.aptar pharma developed a platform of closure components, data and services to accelerate and derisk the choice of drug developers. in this webinar, aptar pharma’s experts will present the series of test that were developed to demonstrate the performance of premiumcoat® etfe. The premiumcoat® platform of components and services combine a pure elastomer formulation, a state of the art process and an etfe film coating technology to maintain the integrity of sensitive injectable drugs. premiumcoat® reduces extractables and leachables to improve the compatibility with the drug and accelerates drug development programs.
Aptar Pharma Hosts Webinar On Derisking The Development Of Sensitive Choosing the right packaging for sensitive drugs, new biotech drugs or biosimilar can be a complex and risky exercise.aptar pharma developed a platform of closure components, data and services to accelerate and derisk the choice of drug developers. in this webinar, aptar pharma’s experts will present the series of test that were developed to demonstrate the performance of premiumcoat® etfe. The premiumcoat® platform of components and services combine a pure elastomer formulation, a state of the art process and an etfe film coating technology to maintain the integrity of sensitive injectable drugs. premiumcoat® reduces extractables and leachables to improve the compatibility with the drug and accelerates drug development programs. Discover premiumcoat, aptar pharma’s etfe film coated platform of vial stoppers, syringe components and services that protects your drug and your patients. premiumcoat® solutions help accelerate and derisk your drug development process by reducing extractables & leachables and ensuring optimal functional performances. In this edition of drug development & delivery, discover our premiumcoat® platform of etfe film coated solutions. claire raynal olive explains how these vial stoppers and pre filled syringe plungers protect sensitive drugs and help derisk product development to reach the market faster. download publication. author (s): c. raynal olive.
Comments are closed.